Objective: Our aim was to evaluate left ventricular (LV) mechanics by using speckle tracking echocardiography (STE) in asymptomatic patients with abnormal origin of the left main coronary artery from the pulmonary trunk (ALCAPA), late after successful repair, in the presence of LV ejection fraction (EF) >50%. Methods: We studied 30 ALCAPA patients (median age 4 years, range 1-25 years, NYHA class I, LVEF >50%) and 16 healthy age- and sex-matched controls (median age 5 years, range 1-25 years). All underwent standard echocardiographic evaluation and STE. Results: LV dimensions and LVEF (63.6 ± 8.2% vs. 64.1 ± 5.1%, p = 0.826) were not different between patients and controls. Diastolic parameters were significantly abnormal in our patients versus controls (E/e' average: 11.9 ± 5.8 vs. 6.6 ± 3.0, p = 0.0014). Global LV longitudinal strain was significantly lower in ALCAPA patients versus controls (-17.6 ± 3.5% vs. -23.4 ± 3.1%, p < 0.0001). LV torsion (9.1 ± 4.9° vs. 11.9 ± 3.3°, p = 0.046) was significantly impaired in ALCAPA patients. Conclusions: After successful repair in asymptomatic ALCAPA patients, despite an LVEF >50%, diastolic function, LV longitudinal deformation and LV torsion remain impaired. We suggest including a detailed study of the diastolic function and cardiac mechanics in the clinical follow-up of these patients to identify the subgroup of patients at higher risk.

1.
Farouk A, Zahka K, Siwik E, Golden A, Karimi M, Uddin M, Hennein HA: Anomalous origin of the left coronary artery from the right pulmonary artery. J Card Surg 2009;24:49-54.
2.
Pena E, Nguyen ET, Merchant N, Dennie G: ALCAPA syndrome: not just a pediatric disease. Radiographics 2009;29:553-565.
3.
Alexi-Meskishvili V, Nasseri BA, Nordmeyer S, Schmitt B, Weng YG, Böttcher W, Hübler M, Berger F, Hetzer R: Repair of anomalous origin of the left coronary artery from the pulmonary artery in infants and children. J Thorac Cardiovasc Surg 2011;142:868-874.
4.
Lange R, Vogt M, Horer J, Cleuziou J, Menzel A, Holper K, Hess J, Schreiber C: Long-term results of repair of anomalous origin of the left coronary artery from the pulmonary artery. Ann Thorac Surg 2007;83:1463-1471.
5.
Ben Ali W, Metton O, Roubertie F, Pouard P, Sidi D, Raisky O, Vouhé PR: Anomalous origin of the left coronary artery from the pulmonary artery: late results with special attention to the mitral valve. Eur J Cardiothorac Surg 2009;36:244-249.
6.
Cabrera AG, Chen DW, Pignatelli RH, Khan MS, Jeewa A, Mery CM, McKenzie ED, Fraser CD Jr: Outcomes of anomalous left coronary artery from pulmonary artery repair: beyond normal function. Ann Thorac Surg 2015;99:1342-1347.
7.
Schmitt B, Bauer S, Kutty S, Nordmeyer S, Nasseri B, Berger F, Alexi-Meskishvili V: Myocardial perfusion, scarring, and function in anomalous left coronary artery from the pulmonary artery syndrome: a long-term analysis using magnetic resonance imaging. Ann Thorac Surg 2014;98:1425-1436.
8.
Smiseth OA, Torp H, Opdahl A, Haugaa KH, Urheim S: Myocardial strain imaging: how useful is it in clinical decision making? Eur Heart J 2016;37:1196-1207.
9.
Forsey J, Friedberg MK, Mertens L: Speckle tracking echocardiography in pediatric and congenital heart disease. Echocardiography 2013;30:447-459.
10.
Di Salvo G, Bulbul Z, Issa Z, Fadel B, Sehly A, Pergola V, Halees Z, Fayyadh M: Left ventricular mechanics after arterial switch operation: a speckle-tracking echocardiography study. J Cardiovasc Med (Hagerstown) 2016;17:217-224.
11.
Yagmur J, Sener S, Acikgoz N, et al: Subclinical left ventricular dysfunction in Behcet's disease assessed by two-dimensional speckle tracking echocardiography. Eur J Echocardiogr 2011;12:536-541.
12.
Di Salvo G, Eyskens B, Claus P, D'hooge J, Bijnens B, Suys B, De Wolf D, Gewillig M, Sutherland GR, Mertens L: Late post-repair ventricular function in patients with origin of the left main coronary artery from the pulmonary trunk. Am J Cardiol 2004;93:506-508.
13.
Levy PT, Machefsky A, Sanchez AA, Patel MD, Rogal S, Fowler S, Yaeger L, Hardi A, Holland MR, Hamvas A, Singh GK: Reference ranges of left ventricular strain measures by two-dimensional speckle-tracking echocardiography in children: a systematic review and meta-analysis. J Am Soc Echocardiogr 2016;29:209-225.
14.
Shivalkar B, Borges M, Daenen W, Gewillig M, Flameng W: ALCAPA syndrome: an example of chronic myocardial hypoperfusion. J Am Coll Cardiol 1994;23:772-778.
15.
Schwartz ML, Jonas RA, Colan S: Anomalous origin of left coronary artery from pulmonary artery: recovery of left ventricular function after dual coronary repair. J Am Coll Cardiol 1997;30:547-553.
16.
Maes A, Flameng W, Nuyts J, Borgers M, Shivalkar B, Ausma J, Bormans G, Schiepers C, de Roo M, Mortelmans L: Histological alterations in chronically hypoperfused myocardium: correlations with PET findings. Circulation 1994;90:735-745.
17.
Secinaro A, Ntsinjana H, Tann O, Schuler PK, Muthurangu V, Hughes M, Tsang V, Taylor AM: Cardiovascular magnetic resonance findings in repaired anomalous left coronary artery to pulmonary artery connection (ALCAPA). J Cardiovasc Magn Reson 2011;16:13-27.
18.
Sengeløv M, Jørgensen PG, Jensen JS, Bruun NE, Olsen FJ, Fritz-Hansen T, Nochioka K, Biering-Sørensen T: Global longitudinal strain is a superior predictor of all-cause mortality in heart failure with reduced ejection fraction. JACC Cardiovasc Imaging 2015;8:1351-1359.
19.
Krishnasamy R, Isbel NM, Hawley CM, Pascoe EM, Burrage M, Leano R, Haluska BA, Marwick TH, Stanton T: Left ventricular global longitudinal strain (GLS) is a superior predictor of all-cause and cardiovascular mortality when compared to ejection fraction in advanced chronic kidney disease. PLoS One 2015;10:e0127044.
20.
Hartlage GR, Kim JH, Strickland PT, Cheng AC, Ghasemzadeh N, Pernetz MA, Clements SD, Williams BR 3rd: The prognostic value of standardized reference values for speckle-tracking global longitudinal strain in hypertrophic cardiomyopathy. Int J Cardiovasc Imaging 2015;31:557-565.
21.
Kusunose K, Goodman A, Parikh R, Barr T, Agarwal S, Popovic ZB, Grimm RA, Griffin BP, Desai MY: Incremental prognostic value of left ventricular global longitudinal strain in patients with aortic stenosis and preserved ejection fraction. Circ Cardiovasc Imaging 2014;7:938-945.
22.
Su HM, Lin TH, Hsu PC, Lee WH, Chu CY, Lee CS, Voon WC, Lai WT, Sheu SH: Global left ventricular longitudinal systolic strain as a major predictor of cardiovascular events in patients with atrial fibrillation. Heart 2013;99:1588-1596.
23.
Ersbøll M, Valeur N, Mogensen UM, Andersen MJ, Møller JE, Velazquez EJ, Hassager C, Søgaard P, Køber L: Prediction of all-cause mortality and heart failure admissions from global left ventricular longitudinal strain in patients with acute myocardial infarction and preserved left ventricular ejection fraction. J Am Coll Cardiol 2013;61:2365-2373.
24.
Lowenthal A, Tacy TA, Behzadian F, Punn R: Echocardiographic predictors of early postsurgical myocardial dysfunction in pediatric patients with aortic valve insufficiency. Pediatr Cardiol 2013;34:1335-1343.
25.
Mascle S, Schnell F, Thebault C, Corbineau H, Laurent M, Hamonic S, Veillard D, Mabo P, Leguerrier A, Donal E: Predictive value of global longitudinal strain in a surgical population of organic mitral regurgitation. J Am Soc Echocardiogr 2012;25:766-772.
26.
Cho GY, Marwick TH, Kim HS, Kim MK, Hong KS, Oh DJ: Global 2-dimensional strain as a new prognosticator in patients with heart failure. J Am Coll Cardiol 2009;54:618-624.
27.
Di Salvo G, Rea A, Mormile A, Limongelli G, D'Andrea A, Pergola V, Pacileo G, Caso P, Calabrò R, Russo MG: Usefulness of bidimensional strain imaging for predicting outcome in asymptomatic patients aged ≤16 years with isolated moderate to severe aortic regurgitation. Am J Cardiol 2012;110:1051-1055.
28.
Rüssel IK, Götte MJ, Bronzwaer JG, Knaapen P, Paulus WJ, van Rossum AC: Left ventricular torsion: an expanding role in the analysis of myocardial dysfunction. JACC Cardiovasc Imaging 2009;2:648-655.
29.
Sengupta PP, Tajik AJ, Chandrasekaran K, Khandheria BK: Twist mechanics of the left ventricle: principles and application. JACC Cardiovasc Imaging 2008;1:366-376.
30.
Tibayan FA, Yun KL, Fann JI, et al: Torsion dynamics in the evolution from acute to chronic mitral regurgitation. J Heart Valve Dis 2002;11:39-46.
31.
Garot J, Pascal O, Diebold B, Derumeaux G, Ovize M, Gueret P: Changes in left ventricular torsion during ischemia-reperfusion. Arch Mal Coeur Vaiss 2002;95:1151-1159.
32.
Nagel E, Stuber M, Lakatos M, Scheidegger MB, Boesiger P, Hess OM: Cardiac rotation and relaxation after anterolateral myocardial infarction. Coron Artery Dis 2000;11:261-267.
33.
Takeuchi M, Nishikage T, Nakai H, Kokumai M, Otani S, Lang RM: The assessment of left ventricular twist in anterior wall myocardial infarction using two-dimensional speckle tracking imaging. J Am Soc Echocardiogr 2007;20:36-44.
34.
Prinzen FW, Arts T, van der Vusse GJ, Coumans WA, Reneman RS: Gradients in fiber shortening and metabolism across ischemic left ventricular wall. Am J Physiol Heart Circ Physiol 1986;250:H255-H264.
35.
Sutherland GR, Di Salvo G, Claus P, D'hooge J, Bijnens B: Strain and strain rate imaging: a new clinical approach to quantifying regional myocardial function. J Am Soc Echocardiogr 2004;17:788-802.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.